Your browser doesn't support javascript.
loading
A highly adaptive microbiome-based association test for survival traits.
Koh, Hyunwook; Livanos, Alexandra E; Blaser, Martin J; Li, Huilin.
Affiliation
  • Koh H; Department of Population Health, New York University School of Medicine, 650 First Avenue, Room 547, New York, NY, 10016, USA.
  • Livanos AE; Department of Medicine, Columbia University Medical Center, New York, NY, 10032, USA.
  • Blaser MJ; Departments of Medicine and Microbiology, New York University School of Medicine, New York, NY, 10016, USA.
  • Li H; Medical Service, New York Harbor Department of Veterans Affairs Medical Center, New York, NY, 10010, USA.
BMC Genomics ; 19(1): 210, 2018 03 20.
Article in En | MEDLINE | ID: mdl-29558893
ABSTRACT

BACKGROUND:

There has been increasing interest in discovering microbial taxa that are associated with human health or disease, gathering momentum through the advances in next-generation sequencing technologies. Investigators have also increasingly employed prospective study designs to survey survival (i.e., time-to-event) outcomes, but current item-by-item statistical methods have limitations due to the unknown true association pattern. Here, we propose a new adaptive microbiome-based association test for survival outcomes, namely, optimal microbiome-based survival analysis (OMiSA). OMiSA approximates to the most powerful association test in two domains 1) microbiome-based survival analysis using linear and non-linear bases of OTUs (MiSALN) which weighs rare, mid-abundant, and abundant OTUs, respectively, and 2) microbiome regression-based kernel association test for survival traits (MiRKAT-S) which incorporates different distance metrics (e.g., unique fraction (UniFrac) distance and Bray-Curtis dissimilarity), respectively.

RESULTS:

We illustrate that OMiSA powerfully discovers microbial taxa whether their underlying associated lineages are rare or abundant and phylogenetically related or not. OMiSA is a semi-parametric method based on a variance-component score test and a re-sampling method; hence, it is free from any distributional assumption on the effect of microbial composition and advantageous to robustly control type I error rates. Our extensive simulations demonstrate the highly robust performance of OMiSA. We also present the use of OMiSA with real data applications.

CONCLUSIONS:

OMiSA is attractive in practice as the true association pattern is unpredictable in advance and, for survival outcomes, no adaptive microbiome-based association test is currently available.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Computer Simulation / Genetic Markers / Computational Biology / Diabetes Mellitus, Type 1 / High-Throughput Nucleotide Sequencing / Microbiota Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans / Male Language: En Journal: BMC Genomics Journal subject: GENETICA Year: 2018 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Computer Simulation / Genetic Markers / Computational Biology / Diabetes Mellitus, Type 1 / High-Throughput Nucleotide Sequencing / Microbiota Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans / Male Language: En Journal: BMC Genomics Journal subject: GENETICA Year: 2018 Type: Article Affiliation country: United States